CXCL12 and breast cancer: By using a murine BC model of lung metastasis, Yu and collaborators found that MSCs maintain an inhibitory tone on lung metastasis formation through the release of the inflammatory chemokine CXCL12 and the up-regulation of the cognate receptor CXCR7 in BC cells (Yu et al., 2017).